220545-25-5

Basic information

• Product Name: L-Tyrosine, N-[[(4R)-5,5-dimethyl-3-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4-thiazolidin yl]carbonyl]-, dimethylcarbamate (ester)
• CAS NO: 220545-25-5
• Molecular Formula: C22H29N5O7S2
• Molecular Weight: 539.634
• Mol File: 220545-25-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: L-Tyrosine, N-[[(4R)-5,5-dimethyl-3-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4-thiazolidin yl]carbonyl]-, dimethylcarbamate (ester)(CAS DataBase Reference)
• NIST Chemistry Reference: L-Tyrosine, N-[[(4R)-5,5-dimethyl-3-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4-thiazolidin yl]carbonyl]-, dimethylcarbamate (ester)(220545-25-5)
• EPA Substance Registry System: L-Tyrosine, N-[[(4R)-5,5-dimethyl-3-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4-thiazolidin yl]carbonyl]-, dimethylcarbamate (ester)(220545-25-5)

Safety Data

• Hazardous Substances Data: 220545-25-5(Hazardous Substances Data)

Upstream product

• 693226-09-4 5,5-dimethyl-3-(1-methyl-1H-pyrazole-4-sulfonyl)-thiazolidine-4-carboxylic acid 
• 72778-00-8 (R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid 
• 220545-24-4 N-(1-methylpyrazole-4-sulfonyl)-L-(5,5-dimethyl)thiaprolyl-L-4-(N,N-dimethylcarbamyloxy)phenylalanine tert-butyl ester 

Relevant articles and documents

STEROID SPARING AGENTS AND METHODS OF USING SAME

This invention relates generally to the use of a steroid sparing agent for the preparation of a medicament for the treatment of inflammatory bowel diseases (IBD), asthma, multiple sclerosis (MS), rheumatoid arthritis (RA), graft versus host disease (GVHD), host versus graft disease, and various spondyloarthropathies, comprising administering a steroid sparing immunoglobulin or small molecule composition to a patient in need thereof. The invention also relates generally to combination therapies for the treatment of these conditions.